Drug industry to oppose substitutive dispensing restriction only for proven drugs of bio-equivalency
against the issue of restricting the substitutive dispensing only for the drugs already proved with its bio-equivalency test in the negotiation between the government and the medical community.
The industry recalled the earli...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
